ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

Amundi's Holding History (CIK: 0001330387)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 5,000,000 Value ($000) $735,150 Avg Close — Range —
Q2 2025
Shares 3,200,000 Value ($000) $4,187 Avg Close — Range —
Q1 2025
Shares 3,200,000 Value ($000) $3,624 Avg Close — Range —
Q4 2024
Shares 3,200,000 Value ($000) $3,448 Avg Close — Range —
Q3 2024
Shares 3,200,000 Value ($000) $3,696 Avg Close — Range —
Q2 2024
Shares 3,200,000 Value ($000) $3,472 Avg Close — Range —
Q1 2024
Shares 3,200,000 Value ($000) $2,940 Avg Close — Range —
Q4 2023
Shares 3,200,000 Value ($000) $3,216 Avg Close — Range —
Q3 2023
Shares 3,854,000 Value ($000) $3,480 Avg Close — Range —